Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07538388 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension

Study acronym: INDUCT-Multi
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites revised (4)
    • Eligibility criteria shortened, about 1 word
    v6
  2. Site details revised at 1 of 4 sitesv5
  3. Site details revised at 1 of 4 sitesv4
  4. Primary endpoint(s) modifiedv3 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Apr 2026 to May 7, 2026
    • Secondary endpoints revised (32)
    • Site details revised at 4 of 4 sites
  5. Secondary endpoints: details revised at 32 of 32 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
INDUCT-Multi is a multicenter randomized trial investigating whether continuous, compared to bolus, administration of norepinephrine during induction of general anesthesia reduces postinduction hypotension in high-risk non-cardiac surgery patients.
Trial Details
NCT Number NCT07538388
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Conditions
(from sponsor)		 Postinduction Hypotension
Related terms Hypotension
Enrollment 446 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov